₹1,482.10
-60.70 (-3.93%)
As of 28 Aug 2026, Concord Biotech Ltd share price is ₹1,482.10. The stock opened at ₹1,482.10 and had closed at ₹1,542.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹987.05 and a high of ₹1,747.95. In terms of performance, Concord Biotech Ltd share price has increased by 21.60% over the past six months and has decreased by 11.85% over the last year.
CONCORDBIO Charts
Concord Biotech Ltd Overview
Market cap₹15,505 Crs
Volume18,096
Prev. Close₹1,542.80
Year range₹987.05 - ₹1,747.95
Total Value₹2,68,20,081.60
ISININE338H01029
About CONCORDBIO
Concord Biotech engaged in the business of manufacturing and trading in pharmaceutical products.
Concord Biotech Ltd Historical Performance
1 Month Return17.91%
6 Month Return21.33%
3 Year Return48.63%
3 Month Return34.81%
1 Year Return-13.07%
5 Year Return-
Concord Biotech Ltd Fundamental Analysis
ROCE(TTM)17.41%
P/E Ratio (TTM)54.99
P/B Ratio7.68
Debt to Equity0.00
ROE13.03%
EPS (TTM)27.18
Dividend Yield0.51%
Book Value193.06
Profit Margin25.58%
Operating Margin29.48%
Concord Biotech Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 273.62 | 341.43 | 288.21 | 260.49 | 217.67 |
| EBITDA | 100.28 | 137.93 | 109.03 | 103.97 | 75.08 |
| Net Profit | 61.19 | 90.02 | 67.78 | 62.90 | 42.57 |
| EPS | 5.85 | 8.60 | 6.48 | 6.01 | 4.07 |
Concord Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 67.30 |
| MACD | 62.41 |
| 20-Day SMA | 1,467.38 |
Concord Biotech Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Concord Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Concord Biotech Ltd today is ₹1,482.10 on NSE and ₹1,482.10 on BSE.
- The 52-week high of Concord Biotech Ltd is ₹1,747.95, while the 52-week low is ₹987.05.
- The current market capitalisation of Concord Biotech Ltd is approximately ₹15,505 crore.
- The P/E (Price-to-Earnings) ratio of Concord Biotech Ltd is 40.52. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Concord Biotech Ltd is 6.90. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Concord Biotech Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Concord Biotech Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Concord Biotech Ltd has delivered a return of approximately 48.63%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Concord Biotech Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 44.08% promoters, 3.13% FIIs, 9.36% DIIs, and 8.23% public shareholders.
